Page 2583 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 2583
Chapter 158 Hematologic Aspects of Parasitic Diseases 2303.e3
97. Fried M, Duffy PE: Adherence of Plasmodium falciparum to chondroi- 122. Dondorp AM, Fanello CI, Hendriksen IC, et al: Artesunate versus
tin sulfate A in the human placenta. Science 272:1502, 1996. quinine in the treatment of severe falciparum malaria in African chil-
98. Beeson JG, Rogerson SJ, Cooke BM, et al: Adhesion of Plasmodium dren (AQUAMAT): an open-label, randomised trial. Lancet 376:1647,
falciparum-infected erythrocytes to hyaluronic acid in placental malaria. 2010.
Nat Med 6:86, 2000. 123. Njuguna P, Newton C: Management of severe falciparum malaria. J
99. Rogerson SJ, Hviid L, Duffy PE, et al: Malaria in pregnancy: patho- Postgrad Med 50:45, 2004.
genesis and immunity. Lancet Infect Dis 7:105, 2007. 124. Dhabangi A, Ainomugisha B, Cserti-Gazdewich C, et al: Effect of
100. Guyatt HL, Snow RW: Malaria in pregnancy as an indirect cause transfusion of red blood cells with longer vs shorter storage duration on
of infant mortality in sub-Saharan Africa. Trans R Soc Trop Med Hyg elevated blood lactate levels in children with severe anemia: the TOTAL
95:569, 2001. randomized clinical trial. JAMA 314:2514–2523, 2015.
101. ter Kuile FO, van Eijk AM, Filler SJ: Effect of sulfadoxine-pyrimethamine 125. Newton CR, Krishna S: Severe falciparum malaria in children: current
resistance on the efficacy of intermittent preventive therapy for malaria understanding of pathophysiology and supportive treatment. Pharmacol
control during pregnancy: a systematic review. JAMA 297:2603, 2007. Ther 79:1, 1998.
102. Bedu-Addo G, Bates I: Causes of massive tropical splenomegaly in 126. Riddle MS, Jackson JL, Sanders JW, et al: Exchange transfusion as
Ghana. Lancet 360:449, 2002. an adjunct therapy in severe Plasmodium falciparum malaria: a meta-
103. Zhu D, Thompsett AR, Bedu-Addo G, et al: VH gene sequences from analysis. Clin Infect Dis 34:1192, 2002.
a novel tropical splenic lymphoma reveal a naive B cell as the cell of 127. Bruce-Chwatt LJ: Transfusion malaria revisited. Trop Dis Bull 79:827,
origin. Br J Haematol 107:114, 1999. 1982.
104. Price RN, Douglas NM, Anstey NM: New developments in Plasmo- 128. Schlagenhauf P, Mueutener P: Imported malaria. In Schlagenhauf-
dium vivax malaria: severe disease and the rise of chloroquine resistance. Lawlor P, editor: Traveler’s malaria, Hamilton, ON, 2001, BC Decker
Curr Opin Infect Dis 22:430, 2009. Inc., p 495.
105. Nosten F, McGready R, Simpson JA, et al: Effects of Plasmodium vivax 129. De Silva M, Contreras M, Barbara J: Two cases of transfusion-
malaria in pregnancy. Lancet 354:546, 1999. transmitted malaria (TTM) in the UK [letter]. Transfusion 28:86, 1988.
106. Gilles HM, Hendrickse RG: Possible aetiological role of Plasmodium 130. Chiodini PL, Hartley S, Hewitt PE, et al: Evaluation of a malaria
malariae in “nephrotic syndrome” in Nigerian children. Lancet 1:806, antibody ELISA and its value in reducing potential wastage of red cell
1960. donations from blood donors exposed to malaria, with a note on a case
107. Warhurst DC, Williams JE: Laboratory diagnosis of malaria—ACP of transfusion-transmitted malaria. Vox Sang 73:143, 1997.
Broadsheet No. 148. J Clin Pathol 49:533, 1996. 131. Kitchen A, Mijovic A, Hewitt P: Transfusion-transmitted malaria:
108. Lewis SM, Bain BJ, Bates I: Dacie and Lewis practical haematology, ed current donor selection guidelines are not sufficient. Vox Sang 88:200,
10, Edinburgh, UK, 2005, Churchill Livingstone. 2005.
109. Bailey JW, Williams J, Bain BJ, et al: Guideline: the laboratory diagnosis 132. Mungai M, Tegtmeier G, Chamberland M, et al: Transfusion-
of malaria. Br J Haematol 163(5):573, 2013. doi:10.1111/bjh.12572. transmitted malaria in the United States from 1963 through 1999. N
110. Moody A: Rapid diagnostic tests for malaria parasites. Clin Microbiol Engl J Med 344:1973, 2001.
Rev 15:66, 2002. 133. Mali S, Tan KR, Arguin PM: Malaria surveillance—United States,
111. Milne LM, Kyi MS, Chiodini PL, et al: Accuracy of routine laboratory 2009. MMWR Surveill Summ 60:1, 2011.
diagnosis of malaria in the United Kingdom. J Clin Pathol 47:740, 134. Kitchen AD, Barbara JA, Hewitt PE: Documented cases of post-
1994. transfusion malaria occurring in England: a review in relation to current
112. Baird JK, Purnomo, Jones TR: Diagnosis of malaria in the field by and proposed donor-selection guidelines. Vox Sang 89:77, 2005.
fluorescence microscopy of QBC capillary tubes. Trans R Soc Trop Med 135. Kitchen AD, Lowe PH, Lalloo K, et al: Evaluation of a malarial
Hyg 86:3, 1992. antibody assay for use in the screening of blood and tissue products
113. Benito A, Roche J, Molina R, et al: Application and evaluation of for clinical use. Vox Sang 87:150, 2004.
QBC malaria diagnosis in a holoendemic area. Appl Parasitol 35:266, 136. Slinger R, Giulivi A, Bodie-Collins M, et al: Transfusion-transmitted
1994. malaria in Canada. CMAJ 164:377, 2001.
114. Bosch I, Bracho C, Perez HA: Diagnosis of malaria by acridine orange 137. Alvar J, Velez ID, Bern C, et al: Leishmaniasis worldwide and global
fluorescent microscopy in an endemic area of Venezuela. Mem Inst estimates of its incidence. PLoS ONE 7:e35671, 2012.
Oswaldo Cruz 91:83, 1996. 138. Ross R: Note on the bodies recently described by Leishman and
115. Huong NM, Davis TM, Hewitt S, et al: Comparison of three antigen Donovan. Br Med J 2:1261, 1903.
detection methods for diagnosis and therapeutic monitoring of malaria: 139. Garnham PC: The leishmanias, with special reference to the role of
a field study from southern Vietnam. Trop Med Int Health 7:304, animal reservoirs. Am Zool 5:141, 1965.
2002. 140. Symmers WS: Leishmaniasis acquired by contagion: a case of marital
116. Lalloo DG, Shingadia D, Bell DJ, et al: UK malaria treatment guide- infection in Britain. Lancet 1:127, 1960.
lines 2016. J Infect 72:635–649, 2016. 141. Campino L, Santos-Gomes G, Pratlong F, et al: The isolation of Leish-
117. McNamara DT, Thomson JM, Kasehagen LJ, et al: Development of a mania donovani MON-18, from an AIDS patient in Portugal: possible
multiplex PCR-ligase detection reaction assay for diagnosis of infection needle transmission. Parasite 1:391, 1994.
by the four parasite species causing malaria in humans. J Clin Microbiol 142. Sampaio MJ, Cavalcanti NV, Alves JG, et al: Risk factors for death in
42:2403, 2004. children with visceral leishmaniasis. PLoS Negl Trop Dis 4:e877, 2010.
118. Rubio JM, Benito A, Berzosa PJ, et al: Usefulness of seminested multi- 143. Badaro R, Jones TC, Carvalho EM, et al: New perspectives on a
plex PCR in surveillance of imported malaria in Spain. J Clin Microbiol subclinical form of visceral leishmaniasis. J Infect Dis 154:1003, 1986.
37:3260, 1999. 144. Magill AJ, Grogl M, Gasser RA, Jr, et al: Visceral infection caused by
119. Benito A, Rubio JM: Usefulness of seminested polymerase chain reac- Leishmania tropica in veterans of Operation Desert Storm. N Engl J
tion for screening blood donors at risk for malaria in Spain. Emerg Infect Med 328:1383, 1993.
Dis 7:1068, 2001. 145. Pratlong F, Dedet JP, Marty P, et al: Leishmania-human immunode-
120. WorldWide Antimalarial Resistance Network (WWARN) Lumefan- ficiency virus coinfection in the Mediterranean basin: isoenzymatic
trine PK/PD Study Group: Artemether-lumefantrine treatment of characterization of 100 isolates of the Leishmania infantum complex. J
uncomplicated Plasmodium falciparum malaria: a systematic review and Infect Dis 172:323, 1995.
meta-analysis of day 7 lumefantrine concentrations and therapeutic 146. Alvar J, Canavate C, Gutierrez-Solar B, et al: Leishmania and human
response using individual patient data. BMC Med 13:227, 2015. immunodeficiency virus coinfection: the first 10 years. Clin Microbiol
121. Woodrow CJ, White NJ: The clinical impact of artemisinin resistance Rev 10:298, 1997.
in Southeast Asia and the potential for future spread. FEMS Microbiol 147. Ramos-Santos C, Hernandez-Montes O, Sanchez-Tejeda G, et al:
Rev 41:34, 2017. Visceral leishmaniosis caused by Leishmania (L.) mexicana in a Mexican

